Pricing Log in Create free account

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) vs Telomir Pharmaceuticals, Inc. (TELO)

Connect Biopharma Holdings Limited Sponsored ADR and Telomir Pharmaceuticals, Inc. are both Biotechnology companies. Connect Biopharma Holdings Limited Sponsored ADR and Telomir Pharmaceuticals, Inc. are of similar size ($43.8M and $43.4M). Telomir Pharmaceuticals, Inc. has the higher net margin (0.00% vs −2,298.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Telomir Pharmaceuticals, Inc. leads on 8 and Connect Biopharma Holdings Limited Sponsored ADR on 4.

Valuation

Metric CNTB TELO Biotechnology median
P/E n/m n/m 11.58
P/S 14.46 n/m 9.61
P/B 1.62 9.21 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 4.03 n/m 9.43
Earnings yield (172.46%) (150.85%) (32.28%)
Free cash flow yield (140.62%) (11.27%) (22.27%)

Profitability

Metric CNTB TELO Biotechnology median
Gross margin 100.00% — 68.81%
Operating margin (2,346.35%) 0.00% 0.00%
Net margin (2,298.93%) 0.00% 0.00%
Free cash flow margin (2,018.76%) 0.00% 0.00%
Return on equity (140.51%) (906.42%) (50.30%)
Return on assets (109.34%) (856.78%) (45.47%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTB TELO Biotechnology median
Revenue growth (TTM) — — 6.78%
EPS growth (last fiscal year) (257.14%) 41.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric CNTB TELO Biotechnology median
Debt to equity 0.01 0.02 0.00
Current ratio 2.37 19.61 4.74
Net debt to EBITDA 0.77 0.69 1.01

Dividend

Metric CNTB TELO Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric CNTB TELO Biotechnology median
Market cap 43.38m 43.84m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack